GALT

Galectin Therapeutics Inc. News Headlines

$4.76
*  
0.33
6.48%
Get GALT Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading GALT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Galectin Therapeutics Issued U.S. Patent For GR-MD-02 In Diabetic Nephropathy
9/15/2014 8:11:00 AM - RTT News


Galectin Therapeutics To Present At Aegis Capital Conference; Webcast At 4:00 PM
9/12/2014 3:00:00 PM - RTT News


Biotechs With Upside Target Ebola And Liver Disease: MLV's Vernon Bernardino
9/11/2014 9:16:00 AM - Seeking Alpha


Biotechs With Insider Buying
8/22/2014 2:16:00 PM - Seeking Alpha


Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside
8/22/2014 12:01:00 PM - Seeking Alpha


Galectin Therapeutics Says Plans To Vigorously Defend Class Action Lawsuit
8/4/2014 8:20:00 AM - RTT News


Sector Update: Health Care Stocks Struggling to Stay Positive; Galectin Therapeutics Tumbles After Liver Drug Fails in Phase I Testing
7/29/2014 1:02:46 PM - MT Newswires


Sector Update: Health Care
7/29/2014 12:54:07 PM - MT Newswires


Galectin Therapeutics: Why This Penny Stock Dressed Up By Stock Promoters Is A Short
7/28/2014 10:32:00 AM - Seeking Alpha


Do The Math: Ram Selvaraju On The Appeal Of Biotechs In Orphan Diseases
4/23/2014 8:48:00 AM - Seeking Alpha


Galectin Therapeutics Rises on GR-MD-02 Update - Analyst Blog
4/21/2014 4:45:01 PM - Zacks.com


Galectin Therapeutics, Inc. (GALT) in Focus: Stock Moves Up 8.84% - Tale of the Tape
3/26/2014 8:44:01 AM - Zacks.com


Upbeat Consumer Confidence Drives Blue Chips Higher
3/25/2014 4:24:08 PM - Schaeffer's Investment Research


Healthcare Stocks Up Briskly in Afternoon Surge; Galectin Therapeutics Surges on Announcement Speculation
3/25/2014 3:52:04 PM - MT Newswires


Sector Update: Healthcare
3/25/2014 3:48:58 PM - MT Newswires


Monday Sector Laggards: Biotechnology, Drugs
3/24/2014 1:40:17 PM - BNK Invest


Sector Update: Healthcare Shares Mixed Pre-Market; Nu Skin Surges 26% on $540 K Fine in China
3/24/2014 8:36:02 AM - MT Newswires


Sector Update: Healthcare
3/24/2014 8:35:44 AM - MT Newswires


Why La Jolla Pharma Has Very Favorable Risk/Reward
2/5/2014 3:52:00 PM - Seeking Alpha


Liver Drug Race: Intercept Pharma Vs. Rivals
1/26/2014 7:24:00 PM - Seeking Alpha


Update on GALT's GR-MD-02 - Analyst Blog
1/23/2014 7:50:01 PM - Zacks.com


Research Notes On Intercept And NASH: A Liver Disease Investors Should Watch
1/13/2014 10:14:00 AM - Seeking Alpha


Healthcare Stocks Adding to Earlier Gains; Big Rally by Intercept Pharma Also Raising Peers
1/9/2014 4:52:29 PM - MT Newswires


Sector Update: Healthcare
1/9/2014 4:50:57 PM - MT Newswires


GALT's GR-MD-02 Gets Patent Protection - Analyst Blog
1/7/2014 7:05:01 PM - Zacks.com